Global Alzheimer’s Disease Diagnostics Market Size Study, by Diagnostic Technique (Biomarkers, Imaging Techniques, Genetic Testing), by Type (Triage, Diagnosis, Screening), by End-Use, and Regional Forecasts 2022-2032

The Global Alzheimer’s Disease Diagnostics Market was valued at approximately USD 7.50 billion in 2023 and is poised to expand at a CAGR of 11.03% over the forecast period 2024-2032. With the prevalence of Alzheimer’s disease escalating at an alarming rate, the urgency for early and precise diagnostics has surged dramatically. Advanced diagnostic techniques leveraging biomarkers, imaging technologies, and genetic testing have revolutionized disease detection, enabling early intervention and paving the way for more effective therapeutic strategies. These innovations are not only enhancing the accuracy of Alzheimer’s diagnosis but also contributing significantly to drug development and personalized medicine approaches, offering a glimpse into the future of neurology and cognitive health management.

The global market is experiencing robust growth due to a confluence of factors. An aging population, coupled with the increasing burden of neurodegenerative diseases, is amplifying the demand for cutting-edge diagnostic solutions. Additionally, continuous advancements in imaging modalities and biomarker-based diagnostics have heightened the precision of disease identification, leading to improved patient outcomes. Governments and research institutions worldwide are pouring substantial investments into Alzheimer’s research, further propelling market expansion. However, the high cost of diagnostic procedures and limited accessibility in emerging economies remain formidable challenges that could impede growth in certain regions.

North America continues to dominate the Alzheimer’s Disease Diagnostics Market, owing to well-established healthcare infrastructure, the presence of key industry players, and increasing awareness campaigns about early disease detection. The United States remains a frontrunner, driven by high healthcare expenditures, strong research initiatives, and favorable reimbursement policies. Europe follows closely, benefiting from increased funding for neurodegenerative disease research and the rapid adoption of technologically advanced diagnostic tools. Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth during the forecast period, bolstered by rising healthcare expenditures in China, India, and Japan, an expanding elderly population, and increased investments in precision medicine.

With mounting concerns over Alzheimer’s disease and the need for breakthrough innovations in diagnostics, the industry is witnessing a surge in collaborations between biotechnology firms, pharmaceutical giants, and research institutions. These partnerships are focused on refining existing diagnostic approaches and developing novel biomarker-based solutions to enable early disease detection. As the landscape of neurodegenerative disease diagnostics continues to evolve, market players are actively engaging in mergers, acquisitions, and strategic alliances to solidify their positions in this rapidly expanding sector.

Major Market Players Included in This Report Are:
• Roche Diagnostics
• Siemens Healthineers
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Eli Lilly and Company
• Bio-Rad Laboratories, Inc.
• Fujirebio Diagnostics, Inc.
• Quest Diagnostics Incorporated
• PerkinElmer Inc.
• C2N Diagnostics
• Neurovision Imaging LLC
• Quanterix Corporation
• Merck KGaA
• Medtronic Plc
• Agilent Technologies, Inc.

The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Diagnostic Technique:
• Biomarkers
• Imaging Techniques
• Genetic Testing

By Type:
• Triage
• Diagnosis
• Screening

By End-Use:
• Hospitals
• Diagnostic Laboratories
• Research Institutions
• Others

By Region:

North America:
• U.S.
• Canada

Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America:
• Brazil
• Mexico

Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of MEA

Years Considered for the Study:
• Historical Year – 2022, 2023
• Base Year – 2023
• Forecast Period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecasts for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level breakdowns of major regions.
• Competitive landscape with strategic insights into key industry players.
• In-depth evaluation of business strategies and recommendations for future market expansion.
• Supply and demand chain analysis to provide a 360-degree market perspective.